A Study to Assess Effectiveness of Venclexta (Venetoclax) in Patients With Relapse or Refractory Chronic Lymphocytic Leukemia in Routine Clinical Practice in Russian Federation
Clinical trial NCT03873857 · COMPLETED
Trial details
- NCT number
- NCT03873857
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-02-25
- Primary completion
- 2022-09-12
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.